iTeos Therapeutics, Inc. ITOS
Set alert
10.15 0.00 0.00%
At close · Aug 29
10.15 Day range 10.15
52-week range unavailable
- YTD
- +32.16%
- 1 year
- -40.82%
- Open
- 10.15
- Prev close
- 10.15
- Mkt cap
- 268.52M
- Vol
- 11.01M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.15
- High
- 10.15
- Forward P/E
- -1.26
- Beta
- 1.39
- Short ratio
- 3.66
- Inst. own
- 103.92%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 8.57
- 200-d avg
- 12.79
- 1y target
- 25.00
Financial health
Altman Z-Score
1.65 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -2.3×
FY 2018 5y median -2.3× FY 2024
P/S 8.9×
FY 2018 5y median 4.8× FY 2024
P/B 0.5×
FY 2018 5y median 1.0× FY 2024
P/FCF -3.1×
FY 2018 5y median -3.7× FY 2024
EV/EBITDA -1.4×
FY 2018 5y median -1.3× FY 2024
EV/Sales 5.0×
FY 2018 5y median 2.3× FY 2024
FCF Yield -32.1%
FY 2018 5y median -16.1% FY 2024
Profitability
Gross Margin 96.5%
FY 2018 5y median 96.5% FY 2024
Operating Margin -455.8%
FY 2018 5y median 0.0% FY 2024
Net Margin -384.0%
FY 2018 5y median 0.0% FY 2024
ROE -22.8%
FY 2018 5y median -11.8% FY 2024
ROIC -24.6%
FY 2018 5y median -13.7% FY 2024
ROA -19.6%
FY 2018 5y median -11.0% FY 2024
Growth (YoY)
Revenue 177.9%
FY 2018 FY 2024
Operating Income -5.6%
FY 2018 FY 2024
EPS (diluted) -5.4%
FY 2018 FY 2024
Free Cash Flow 6.5%
FY 2018 FY 2024
Financial Health
Current Ratio 12.6×
FY 2018 5y median 13.8× FY 2024
Quick Ratio 12.6×
FY 2018 5y median 13.8× FY 2024
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2024
Net Debt / EBITDA 1.1×
FY 2018 5y median 1.1× FY 2024
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2024
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31